MoneyWorks4Me

The sales is pegged at Rs. 390.60 millions for the March 2025 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 413.98 millions during the year-ago period.A slender decline of -9.89% was recorded to Rs. 13.12  millions from Rs. 14.56 millions in the corresponding previous quarter.Operating Profit saw a handsome growth to 41.38 millions from 34.03 millions in the quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 390.60 413.98 -5.65 1458.57 1524.66 -4.33 1458.57 1524.66 -4.33
Other Income 10.25 5.15 99.03 27.42 35.22 -22.15 27.42 35.22 -22.15
PBIDT 41.38 34.03 21.60 139.19 146.34 -4.89 139.19 146.34 -4.89
Interest 8.22 6.76 21.60 27.31 22.90 19.26 27.31 22.90 19.26
PBDT 15.27 27.27 -44.00 90.42 123.44 -26.75 90.42 123.44 -26.75
Depreciation 2.15 12.71 -83.08 48.90 49.95 -2.10 48.90 49.95 -2.10
PBT 13.12 14.56 -9.89 41.52 73.49 -43.50 41.52 73.49 -43.50
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 13.12 14.56 -9.89 41.52 73.49 -43.50 41.52 73.49 -43.50
Equity 236.56 236.56 0.00 236.56 236.56 0.00 236.56 236.56 0.00
PBIDTM(%) 10.59 8.22 28.88 9.54 9.60 -0.58 9.54 9.60 -0.58

Bafna Pharmaceutical Share Price

262.40 -5.35 (-2.00%)
14-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1924.90
Dr. Reddys Labs. 1202.00
Cipla 1450.00
Lupin 2235.00
Zydus Lifesciences 1140.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: